JP5275779B2 - Whitening agent and external preparation for skin - Google Patents
Whitening agent and external preparation for skin Download PDFInfo
- Publication number
- JP5275779B2 JP5275779B2 JP2008325423A JP2008325423A JP5275779B2 JP 5275779 B2 JP5275779 B2 JP 5275779B2 JP 2008325423 A JP2008325423 A JP 2008325423A JP 2008325423 A JP2008325423 A JP 2008325423A JP 5275779 B2 JP5275779 B2 JP 5275779B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- whitening
- pine
- external preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 38
- 230000002087 whitening effect Effects 0.000 title description 64
- 239000000284 extract Substances 0.000 claims description 112
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 240000005020 Acaciella glauca Species 0.000 claims description 16
- 235000008582 Pinus sylvestris Nutrition 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 10
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 10
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 230000002401 inhibitory effect Effects 0.000 claims description 6
- 230000008099 melanin synthesis Effects 0.000 claims description 6
- 229960000271 arbutin Drugs 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 5
- 235000018782 Dacrydium cupressinum Nutrition 0.000 claims description 3
- 235000013697 Pinus resinosa Nutrition 0.000 claims description 3
- 241000218626 Pinus sylvestris Species 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 235000011613 Pinus brutia Nutrition 0.000 description 24
- 241000018646 Pinus brutia Species 0.000 description 21
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 18
- -1 For example Substances 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 241000218641 Pinaceae Species 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 239000007844 bleaching agent Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000002845 discoloration Methods 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 229960004705 kojic acid Drugs 0.000 description 5
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 5
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 235000005205 Pinus Nutrition 0.000 description 4
- 241000218602 Pinus <genus> Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 208000001382 Experimental Melanoma Diseases 0.000 description 3
- 241000218652 Larix Species 0.000 description 3
- 235000005590 Larix decidua Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000008670 Pinus densiflora Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229940123973 Oxygen scavenger Drugs 0.000 description 2
- 235000000405 Pinus densiflora Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- XPXZDHXJQITWQI-UHFFFAOYSA-N butane-1,3-diol;hydrate Chemical compound O.CC(O)CCO XPXZDHXJQITWQI-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- 235000020221 chamomile extract Nutrition 0.000 description 2
- 229940119217 chamomile extract Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- GLXBPZNFNSLJBS-UHFFFAOYSA-N 11-methyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCC(C)C GLXBPZNFNSLJBS-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical class CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- HIPQTCQUXOFTFI-UHFFFAOYSA-N 2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)C(=O)C1=CC=CC=C1 HIPQTCQUXOFTFI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 240000001436 Antirrhinum majus Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241001316290 Gypsophila Species 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 240000005074 Hymenocallis caribaea Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 239000001839 pinus sylvestris Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 229940069774 quince extract Drugs 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000013097 stability assessment Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、美白剤及びそれを含有する皮膚外用剤に関する。 The present invention relates to a whitening agent and a skin external preparation containing the same.
化粧料等の皮膚外用剤の有効成分として、種々の植物由来の成分が利用されている。例えば、マツ科植物の樹皮の抽出物には、チロシナーゼ活性阻害作用及びマトリックスメタプロテアーゼ活性阻害作用が知られていて化粧料等の皮膚外用剤に利用することが提案されている(特許文献1〜4)。また、特許文献5には、イヌカラマツ抽出物を含有する皮膚外用剤、及び特許文献6には、マツ科の植物又はその溶媒抽出物を含有する皮膚外用剤が、それぞれ提案されているが、特許文献5では、「イヌカラマツ抽出物」とはイヌカラマツの樹皮または根皮の抽出物であることが記載され、及び特許文献6では、好ましい使用部位として幹又は樹皮が例示され、実施例により実際に効果が確認されているのはマツ科植物の樹皮の抽出物についてのみである。また、特許文献7には、マツの抽出物を含有する化粧料等が提案され、その保湿作用が確認されているが、マツのいずれの部位の抽出物であるかについては、記載がない。また、特許文献8には、松等の植物群から少なくとも1種類以上を選択し抽出して得られるクロロゲン酸とパンテトン酸等からなる抽出液と、茶の浸出液、とを配合してなる薬用化粧品が提案され、その美白作用が確認されているが、実際に松のいずれの部位の抽出液を使用したかについては記載がない。
この様に、上記特許文献には、マツ科植物の樹皮、根皮、又は幹の部位の抽出物について、その美白作用等の効能が記載されているものの、マツ科植物の球果の抽出物について、その美白作用等の効能を具体的に示す記載はない。
Thus, although the above-mentioned patent document describes the effect of the whitening action, etc., on the extract of the bark, root bark or stem part of the pine plant, the extract of the pine cone of the pine plant There is no description specifically showing the effect of the whitening action or the like.
ところで、従来、美白作用のある植物抽出物が種々知られているが、充分な美白効果を得るという観点から、実際には、アルブチンやアスコルビン酸及びその誘導体、コウジ酸、エラグ酸などの美白剤が汎用されている。しかし、これらの汎用されている美白剤は美白効果に優れるものの、皮膚外用剤中への配合に制約が多く、これらの美白剤を含有する皮膚外用剤は、経時的に変色もしくは着色、分離、及び結晶析出等の種々の問題が生じ易い。さらに、べたつきがあるなど肌感触について欠点がある。 By the way, conventionally, various plant extracts having a whitening effect are known. From the viewpoint of obtaining a sufficient whitening effect, actually, whitening agents such as arbutin, ascorbic acid and derivatives thereof, kojic acid, and ellagic acid. Is widely used. However, although these commonly used whitening agents are excellent in whitening effect, there are many restrictions on blending into the external preparation for skin, and external preparations containing these whitening agents are discolored or colored over time, separated, In addition, various problems such as crystal precipitation are likely to occur. In addition, there are drawbacks to skin feel such as stickiness.
本発明は、上記問題に鑑みなされたものであり、皮膚外用剤に容易に配合でき、美白効果が高い美白剤、及びそれを含有した安定性が良く、肌感触が良好で、及び高い美白作用のある皮膚外用剤を提供することを課題とする。 The present invention has been made in view of the above problems, and can be easily blended into an external preparation for skin, and has a high whitening effect, and has a good stability, a good skin feel, and a high whitening effect. It is an object of the present invention to provide an external preparation for skin.
本発明は前記課題を解決するため、マツ科マツ属の球果の抽出物を有効成分とする美白剤、及びそれを含有する皮膚外用剤を提供する。
本発明の美白剤は、メラニン産生抑制能を有する美白剤である。
前記マツ科マツ属の植物の例には、セイヨウアカマツが含まれる。
また、本発明の皮膚外用剤は、他の美白剤を含有していてもよく、その例としては、アスコルビン酸又はその誘導体、及びアルブチンから選ばれる一種以上が好ましい。
[MEANS TO SOLVE THE PROBLEM] In order to solve the said subject, this invention provides the whitening agent which uses the extract of the pine genus Pinus cone as an active ingredient, and the skin external preparation containing it.
The whitening agent of the present invention is a whitening agent having an ability to suppress melanin production.
Examples of the plant belonging to the genus Pinus include Pinus densiflora.
Moreover, the skin external preparation of this invention may contain the other whitening agent, As an example, 1 or more types chosen from ascorbic acid or its derivative (s), and arbutin are preferable.
本発明によれば、水系剤型や乳化剤型等、剤型を選ばずに幅広く皮膚外用剤に容易に配合でき、優れた美白効果を有する美白剤を提供することができる。
また、本発明によれば、優れた美白作用を示すとともに、安定性が良好で、肌感触も良好で、及び高い美白作用のある用皮膚外用剤を提供することができる。
ADVANTAGE OF THE INVENTION According to this invention, the whitening agent which can be easily mix | blended easily with skin external preparations widely without choosing dosage forms, such as an aqueous | water-based dosage form and an emulsifier type | mold, and has the outstanding whitening effect can be provided.
Moreover, according to this invention, while showing the outstanding whitening effect, stability is favorable, the skin feel is also favorable, and the skin external preparation for skin with a high whitening effect can be provided.
以下、本発明について詳細に説明する。なお、本明細書において、「〜」はその前後の数値を含む範囲を意味するものとする。
本発明は、マツ科マツ属の球果の抽出物を有効成分とする美白剤に関する。マツ科マツ属の他の部位の抽出物については、上記した通り、チロシナーゼ活性阻害能が確認されている。しかし、部位によっては、その抽出物の細胞毒性が強いため、そのチロシナーゼ活性阻害能に起因する美白効果を得るのに充分な程度まで、高濃度で配合するのが困難な場合がある。本発明者が鋭意検討した結果、マツ科マツ属の球果の抽出物は、高いメラニン産生抑制能を有し、しかも細胞毒性が低いことを見出した。さらに、マツ科マツ属の球果の抽出物は、べたつき感といった不快な皮膚感触を生じさせることなく、高い美白作用を発揮するので、皮膚に適用される皮膚外用剤への利用に適している。
Hereinafter, the present invention will be described in detail. In the present specification, “to” means a range including numerical values before and after.
The present invention relates to a whitening agent comprising as an active ingredient an extract of a pine cone of the genus Pinaceae. As described above, the extract of other parts of the genus Pinaceae has been confirmed to inhibit tyrosinase activity. However, depending on the site, since the cytotoxicity of the extract is strong, it may be difficult to formulate at a high concentration to a degree sufficient to obtain a whitening effect due to its ability to inhibit tyrosinase activity. As a result of intensive studies by the present inventors, it has been found that an extract of the pine genus Pinus has high melanin production-inhibiting ability and low cytotoxicity. Furthermore, the extract of the pine genus Pinus spp. Is suitable for use as a skin external preparation applied to the skin because it exhibits a high whitening effect without causing unpleasant skin feeling such as stickiness. .
前記マツ科マツ属(Pinus densiflora)植物としては、セイヨウアカマツ(Pinus sylvestris Linne (Pinaceae):別名 ヨーロッパアカマツ)が好ましい。本発明では、マツ科マツ属の球果、所謂まつぼっくりの抽出物を用いる。抽出は一般的な方法に従って行うことができる。具体的には、セイヨウアカマツ等のマツ科マツ属植物の球果を抽出溶媒に所定の時間浸漬することによって調製することができる。所望により加熱又は加圧下で行ってもよい。また、抽出を容易にするために、球果を小片に裁断する、及び粉状に粉砕する等の前処理を行ってもよい。 As the Pinus densiflora plant, Pinus sylvestris Linne (Pinaceae) is also preferable. In the present invention, a cone of Pinaceae, a so-called pine cone extract is used. The extraction can be performed according to a general method. Specifically, it can be prepared by immersing a cone of a Pinus pine plant such as Scots pine in an extraction solvent for a predetermined time. If desired, it may be carried out under heating or pressure. Further, in order to facilitate extraction, pretreatment such as cutting the cone into small pieces and pulverizing it into powder may be performed.
抽出溶媒としては特に限定されないが、例えば、水;メチルアルコール、エチルアルコール等の低級一価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール;アセトン等のケトン類;エチルエーテル等のエーテル類;酢酸エチル等のエステル類;等の1種又は2種以上を用いることができる。水、低級一価アルコール、及び液状多価アルコール、並びに水−低級一価アルコール混合液、及び水−液状多価アルコール混合液が好ましい。また、1%程度の尿素を添加した、低級一価アルコール及び液状多価アルコールも好ましい。 Although it does not specifically limit as an extraction solvent, For example, Water; Lower monohydric alcohols, such as methyl alcohol and ethyl alcohol; Liquid polyhydric alcohols, such as glycerol, propylene glycol, and 1, 3- butylene glycol; Ketones, such as acetone; Ethyl One or more of ethers such as ether; esters such as ethyl acetate; and the like can be used. Water, lower monohydric alcohol, and liquid polyhydric alcohol, and water-lower monohydric alcohol mixed solution and water-liquid polyhydric alcohol mixed solution are preferable. Also preferred are lower monohydric alcohols and liquid polyhydric alcohols to which about 1% urea is added.
抽出によって得られた抽出物は、そのまま美白剤として用いることもできるし、適宜の期間そのまま放置し熟成させた後に用いることもできる。必要ならば、本発明の効果に影響のない範囲で、更に、濾過又はイオン交換樹脂等により、脱臭、脱色等の精製処理を施して用いることもできる。又、液体クロマトグラフィー等の分離手段を用い、活性の高い画分を取り出して用いることもできる。 The extract obtained by the extraction can be used as it is as a whitening agent, or it can be used as it is after standing for aging for an appropriate period. If necessary, it can be used after being subjected to a purification treatment such as deodorization and decolorization by filtration or ion exchange resin within a range that does not affect the effect of the present invention. Further, a fraction having high activity can be taken out and used by using a separation means such as liquid chromatography.
前記抽出物は、液状、ペースト状、ゲル状等いずれの形態であってもよい。抽出溶媒を含む液状の抽出物を、減圧乾燥、又は凍結乾燥などにより乾固させて固体状とした後に用いることもできる。また、スプレードライ等により乾燥させて粉末として用いることもできる。 The extract may be in any form such as liquid, paste or gel. The liquid extract containing the extraction solvent can also be used after it is solidified by drying under reduced pressure or freeze drying. It can also be dried by spray drying or the like and used as a powder.
また、マツ科マツ属の球果抽出物は、市販されているものもあり、例えば、セイヨウアカマツの球果の抽出物は、「マツカサ抽出液BG」、「ベゲトール水溶性マツ」の商品名で種々提供されているので、これらをそのまま、または処理等した後、本発明の美白剤として利用することもできる。 Also, there are commercially available pinecone extracts of the genus Pinaceae, for example, the extract of pinus cone of Pinus densiflora under the trade names “Matsukasa extract BG” and “Betetol water-soluble pine”. Since they are variously provided, they can be used as the whitening agent of the present invention as they are or after being treated.
本発明は、本発明の美白剤、即ちマツ科マツ属の球果抽出物、を有効成分として含有する皮膚外用剤にも関する。本発明の皮膚外用剤は、前記球果抽出物による高い美白作用を示すので、皮膚に適用することにより皮膚を白くする又は皮膚の黒化を予防もしくは改善する作用を示す、美白用皮膚外用剤として有用である。前記球果抽出物の皮膚外用剤における含有量は、乾燥固形分に換算して好ましくは0.00001〜1質量%(以下単に「%」で示す)であり、より好ましくは0.0001〜0.1%である。この範囲内であれば、前記抽出物を安定に配合することができ、かつ高い美白効果を発揮することができる。又、溶液として抽出物を使用する場合は、溶質である乾燥固形分の含有量が上記範囲内であれば、その抽出液濃度は何ら限定されるものではない。 The present invention also relates to an external preparation for skin containing the whitening agent of the present invention, that is, a cone extract of the genus Pinaceae as an active ingredient. Since the external preparation for skin of the present invention exhibits a high whitening effect by the cone extract, the external preparation for whitening exhibits an action of whitening the skin or preventing or improving the blackening of the skin when applied to the skin. Useful as. The content of the cone extract in the external preparation for skin is preferably 0.00001 to 1% by mass (hereinafter simply referred to as “%”), more preferably 0.0001 to 0 in terms of dry solid content. 0.1%. If it exists in this range, the said extract can be mix | blended stably and the high whitening effect can be exhibited. When the extract is used as a solution, the concentration of the extract is not limited as long as the content of the dry solid content as a solute is within the above range.
本発明の皮膚外用剤は、本発明の美白剤とともに、他の美白剤を含有していてもよい。他の美白剤の例には、アスコルビン酸又はその誘導体、アルブチン、リノール酸、ビタミンE及びその誘導体、グリチルリチン酸及びその誘導体、トラネキサム酸、胎盤抽出物、カミツレ抽出物、カンゾウ抽出物、エイジツ抽出物、オウゴン抽出物、海藻抽出物、クジン抽出物、ケイケットウ抽出物、ゴカヒ抽出物、コメヌカ抽出物、小麦胚芽抽出物、サイシン抽出物、サンザシ抽出物、サンペンズ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、大豆抽出物、茶抽出物、糖蜜抽出物、ビャクレン抽出物、ブドウ抽出物、ホップ抽出物、マイカイカ抽出物、モッカ抽出物、ユキノシタ抽出物等が含まれる。中でも、他の美白剤としては、アスコルビン酸又はその誘導体、アルブチンから選ばれる一種以上が好ましい。これらの美白剤は、高い美白効果を奏するが、一方、高濃度配合が経時安定性及び使用感の点で困難な場合がある。本発明の美白剤と併用することで、経時安定性及び使用感を損なうことなく、従来の美白用皮膚外用剤の美白効果以上の美白効果を得ることができる。前記他の美白剤と本発明の美白剤との配合比(他の美白剤/本発明の美白剤)は、質量比で3000:1〜1:3000であるのが好ましく、より高い美白効果が得られる点から300:1〜1:300であるのがより好ましい。 The external preparation for skin of the present invention may contain other whitening agents together with the whitening agent of the present invention. Examples of other whitening agents include ascorbic acid or derivatives thereof, arbutin, linoleic acid, vitamin E and derivatives thereof, glycyrrhizic acid and derivatives thereof, tranexamic acid, placenta extract, chamomile extract, licorice extract, age extract , Ogon extract, seaweed extract, cucumber extract, caquette extract, gokahi extract, rice bran extract, wheat germ extract, saicin extract, hawthorn extract, sun penz extract, white lily extract, peonies extract, Sempukuka extract, soybean extract, tea extract, molasses extract, sandalwood extract, grape extract, hop extract, micaika extract, mokka extract, yukinoshita extract and the like. Among them, the other whitening agent is preferably one or more selected from ascorbic acid or a derivative thereof and arbutin. These whitening agents have a high whitening effect, but on the other hand, high concentration blending may be difficult in terms of stability over time and usability. By using together with the whitening agent of the present invention, it is possible to obtain a whitening effect that is more than the whitening effect of the conventional skin whitening preparation for whitening without impairing the stability over time and the feeling of use. The blending ratio of the other whitening agent and the whitening agent of the present invention (other whitening agent / whitening agent of the present invention) is preferably 3000: 1 to 1: 3000 in terms of mass ratio, and has a higher whitening effect. It is more preferable that it is 300: 1 to 1: 300 from the point obtained.
また、本発明の皮膚外用剤を調製するにあたり、本発明の効果を損なわない範囲で他の有効成分、例えば、老化防止効果、又は紫外線暴露によるシワ形成抑効果等を奏する他の有効成分、を配合してもよい。より具体的には、紫外線防御剤、抗菌剤、抗炎症剤、細胞賦活剤、活性酸素除去剤、保湿剤などを挙げることができるが、これらに限定されることはない。 Further, in preparing the external preparation for skin of the present invention, other active ingredients that do not impair the effects of the present invention, such as anti-aging effects, or other active ingredients that exhibit wrinkle formation suppression effects by exposure to ultraviolet rays, You may mix | blend. More specifically, examples include, but are not limited to, UV protection agents, antibacterial agents, anti-inflammatory agents, cell activators, active oxygen scavengers, and moisturizers.
紫外線防御剤としては、例えば、パラメトキシケイ皮酸−2−エチルヘキシル、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−硫酸ナトリウム、4−t−ブチル−4’−メトキシジベンゾイルメタン、2−フェニル−ベンズイミダゾール−5−硫酸、酸化チタン、酸化亜鉛等が挙げられる。 Examples of the UV protection agent include paramethoxycinnamate-2-ethylhexyl, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5 sodium sulfate, 4-t-butyl-4′- Examples thereof include methoxydibenzoylmethane, 2-phenyl-benzimidazole-5-sulfuric acid, titanium oxide, and zinc oxide.
抗菌剤としては、例えば、安息香酸、安息香酸ナトリウム、パラオキシ安息香酸エステル、塩化ベンザルコニウム、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。 Examples of the antibacterial agent include benzoic acid, sodium benzoate, p-hydroxybenzoate ester, benzalkonium chloride, phenoxyethanol, isopropylmethylphenol, and the like.
抗炎症剤は日焼け後の皮膚のほてりや紅斑等の炎症を抑制する作用を有しており、例えば、イオウ及びその誘導体、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、アルテア抽出物、アシタバ抽出物、アルニカ抽出物、インチンコウ抽出物、イラクサ抽出物、オウバク抽出物、オトギリソウ抽出物、カミツレ抽出物、キンギンカ抽出物、クレソン抽出物、コンフリー抽出物、サルビア抽出物、シコン抽出物、シソ抽出物、シラカバ抽出物、ゲンチアナ抽出物等が挙げられる。 Anti-inflammatory agents have the effect of suppressing inflammation such as hot flashes and erythema after sunburn. For example, sulfur and its derivatives, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, Altea extract, Ashitaba extract , Arnica extract, Ginseng extract, nettle extract, Duckweed extract, Hypericum extract, Chamomile extract, Snapdragon extract, Watercress extract, Comfrey extract, Salvia extract, Bamboo extract, Perilla extract , Birch extract, gentian extract and the like.
細胞賦活剤は肌荒れの改善等の目的で用いられ、例えば、カフェイン、鶏冠抽出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ラクトフェリン又はその分解物、コンドロイチン硫酸、ヒアルロン酸等のムコ多糖類またはそれらの塩、コラーゲン、酵母抽出物、乳酸菌抽出物、ビフィズス菌抽出物、醗酵代謝抽出物、イチョウ抽出物、オオムギ抽出物、センブリ抽出物、タイソウ抽出物、ニンジン抽出物、ローズマリー抽出物、グリコール酸、クエン酸、乳酸、リンゴ酸、酒石酸、コハク酸等が挙げられる。 Cell activators are used for the purpose of improving rough skin, such as caffeine, chicken crown extract, shell extract, shell extract, royal jelly, silk protein and its degradation products or derivatives thereof, lactoferrin or degradation products thereof. , Mucopolysaccharides such as chondroitin sulfate and hyaluronic acid or their salts, collagen, yeast extract, lactic acid bacteria extract, bifidobacteria extract, fermentation metabolic extract, ginkgo biloba extract, barley extract, assembly extract, lysium extract Products, carrot extract, rosemary extract, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, succinic acid and the like.
活性酸素除去剤は、過酸化脂質生成抑制等の作用を有しており、例えば、スーパーオキサイドディスムターゼ、マンニトール、クエルセチン、カテキン及びその誘導体、ルチン及びその誘導体、ボタンピ抽出物、ヤシャジツ抽出物、メリッサ抽出物、羅漢果抽出物、レチノール及びその誘導体、カロチノイド等のビタミンA類、チアミンおよびその誘導体、リボフラビンおよびその誘導体、ピリドキシンおよびその誘導体、ニコチン酸およびその誘導体等のビタミンB類、トコフェロール及びその誘導体等のビタミンE類、ジブチルヒドロキシトルエン及びブチルヒドロキシアニソール等が挙げられる。 The active oxygen scavenger has an action such as suppression of lipid peroxide production. For example, superoxide dismutase, mannitol, quercetin, catechin and derivatives thereof, rutin and derivatives thereof, button pi extract, yashajitsu extract, melissa extract , Lanahan fruit extract, retinol and its derivatives, vitamin A such as carotenoid, thiamine and its derivative, riboflavin and its derivative, pyridoxine and its derivative, vitamin B such as nicotinic acid and its derivative, tocopherol and its derivative, etc. Vitamin E, dibutylhydroxytoluene, butylhydroxyanisole, etc. are mentioned.
保湿剤としては、例えば、エラスチン、ケラチン等のタンパク質またはそれらの誘導体、加水分解物並びにそれらの塩、グリシン、セリン、アスパラギン酸、グルタミン酸、アルギニン、テアニン等のアミノ酸及びそれらの誘導体、ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、蔗糖およびその誘導体、デキストリン及びその誘導体、ハチミツ等の糖類、D−パンテノール及びその誘導体、尿素、リン脂質、セラミド、オウレン抽出物、ショウブ抽出物、ジオウ抽出物、センキュウ抽出物、ゼニアオイ抽出物、タチジャコウソウ抽出物、ドクダミ抽出物、ハマメリス抽出物、ボダイジュ抽出物、マロニエ抽出物、マルメロ抽出物等が挙げられる。 Examples of the humectant include proteins such as elastin and keratin or derivatives thereof, hydrolysates and salts thereof, amino acids such as glycine, serine, aspartic acid, glutamic acid, arginine and theanine and derivatives thereof, sorbitol, erythritol, Trehalose, inositol, glucose, sucrose and derivatives thereof, dextrin and derivatives thereof, saccharides such as honey, D-panthenol and derivatives thereof, urea, phospholipid, ceramide, auren extract, ginger extract, diautum extract, sensyu extract Product, mallow extract, gypsophila extract, dokudami extract, hamamelis extract, bodaige extract, maronier extract, quince extract and the like.
また、本発明の皮膚外用剤には、本発明の美白剤以外の任意の成分を配合することができる。そのような成分としては、例えば、アミノ酸、脂質、糖、ホルモン、酵素、核酸などの生理活性物質等を挙げることができるが、これらに限定されることはない。また、本発明の効果を損なわない範囲で、化粧料や医薬部外品、皮膚外用剤等の製造に通常使用される成分、例えば、水(精製水、温泉水、深層水等)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、包接化合物、香料、消臭剤、塩類、pH調整剤、清涼剤、植物・動物・微生物由来の抽出物、血行促進剤、収斂剤、抗脂漏剤、キレート剤、角質溶解剤、酵素、ホルモン類、他のビタミン類等を必要に応じて用いることができる。 Moreover, arbitrary components other than the whitening agent of this invention can be mix | blended with the skin external preparation of this invention. Examples of such components include, but are not limited to, physiologically active substances such as amino acids, lipids, sugars, hormones, enzymes, and nucleic acids. In addition, components that are usually used in the production of cosmetics, quasi-drugs, skin external preparations and the like, for example, water (purified water, hot spring water, deep water, etc.), oil agents, Surfactant, metal soap, gelling agent, powder, alcohol, water-soluble polymer, film-forming agent, resin, inclusion compound, fragrance, deodorant, salt, pH adjuster, refreshing agent, plant / animal -Extracts derived from microorganisms, blood circulation promoters, astringents, antiseborrheic agents, chelating agents, keratolytic agents, enzymes, hormones, other vitamins and the like can be used as necessary.
本発明の皮膚外用剤は、パウダー、パウダーファンデーション等の粉体;石けん、リップスティック等の固体;クリーム、乳液、クリームファンデーション等の乳化物;化粧水、美容液等の液体;など、種々の形態の化粧料組成物であるのが好ましい。但し、これらに限定されるものではない。 The external preparation for skin of the present invention has various forms such as powders such as powder and powder foundation; solids such as soap and lipstick; emulsions such as cream, emulsion and cream foundation; It is preferable that it is a cosmetic composition. However, it is not limited to these.
以下、本発明を実施例によりさらに具体的に説明するが、本発明の範囲は下記の実施例に限定されることはない。なお、以下「部」とは、特に断らない限り、「質量部」を意味する。 Hereinafter, the present invention will be described more specifically with reference to examples. However, the scope of the present invention is not limited to the following examples. Hereinafter, “part” means “part by mass” unless otherwise specified.
[例1:セイヨウアカマツ球果の抽出物の調製]
セイヨウアカマツの球果を細切し、水−エチルアルコールの混合液(エチルアルコールを50vol%含む)を用い抽出し、得られた抽出液を乾燥させて粉末状にしてセイヨウアカマツ球果の抽出物を得た。
[Example 1: Preparation of extract of Scots pine cone]
Scots pine cones are shredded and extracted with a mixed solution of water-ethyl alcohol (containing 50 vol% ethyl alcohol), and the resulting extract is dried to a powder and extracted from Scots pine cones Got.
[例2(比較例用):シベリア落葉松(球果以外の部位)抽出物の調製]
シベリア落葉松の辺材部の形成層及び木部について、例1と同様に抽出処理し、シベリア落葉松(球果以外の部位)抽出物を得た。
[Example 2 (for comparative example): Preparation of Siberian deciduous pine (parts other than cones) extract]
The formation layer and the xylem of the siberian deciduous pine sapwood were extracted in the same manner as in Example 1 to obtain an extract of siberian deciduous pine (parts other than cones).
[例3:細胞培養によるメラニン生成抑制効果(白色化率)及び細胞生育率試験]
マウス由来のB16メラノーマ培養細胞を使用し、上記で調製したセイヨウアカマツ球果抽出物について、メラニン生成抑制効果及び細胞生育率を調べた。
具体的には、2枚の6穴プレートに10vol/vol%FBS含有MEM培地を適量とり、B16メラノーマ細胞を播種し、37℃、二酸化炭素濃度5%中にて静置した。翌日、例1で調製したセイヨウアカマツ球果抽出物を、培地に対してその最終濃度が0μg/mL(対照)、40μg/mL、80μg/mL、120μg/mL、160μg/mL、200μg/mLとなるように添加し、混和した。培養5日目に培地を交換し、再度検体調製液を添加した。翌日、培地を除き、1枚のプレートについて、細胞をリン酸緩衝液にて洗浄した後、回収し、B16メラノーマ培養細胞の白色化度を以下の基準にて評価した。なお、比較対照の陽性コントロールとして美白効果が既知であるコウジ酸を用いた。
(判定基準)
++:コウジ酸200ug/mLを添加した試料と同程度の美白効果を示す。
+:コウジ酸100ug/mLを添加した試料と同程度の美白効果を示す。
±:コウジ酸50ug/mLを添加した試料と同程度の美白効果を示す。
−:美白効果なし。
n.d.:細胞生育率が低く、判定できず。
[Example 3: Melanin production inhibitory effect (whitening rate) and cell growth rate test by cell culture]
B16 melanoma cultured cells derived from mice were used to examine the melanin production inhibitory effect and cell growth rate of the pine cone extract extracted above.
Specifically, an appropriate amount of 10 vol / vol% FBS-containing MEM medium was taken in two 6-well plates, seeded with B16 melanoma cells, and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5%. The next day, the red pine cone extract prepared in Example 1 has a final concentration of 0 μg / mL (control), 40 μg / mL, 80 μg / mL, 120 μg / mL, 160 μg / mL, and 200 μg / mL with respect to the medium. Were added and mixed. On day 5 of the culture, the medium was changed, and the sample preparation solution was added again. On the next day, the medium was removed, and the cells were washed with phosphate buffer on one plate and then collected, and the degree of whiteness of the cultured B16 melanoma cells was evaluated according to the following criteria. In addition, kojic acid with known whitening effect was used as a positive control for comparison.
(Criteria)
++: A whitening effect comparable to that of a sample to which 200 ug / mL of kojic acid is added is shown.
+: A whitening effect comparable to that of the sample to which 100 ug / mL of kojic acid was added is shown.
±: A whitening effect comparable to that of the sample to which 50 ug / mL of kojic acid was added.
-: No whitening effect.
n. d. : Cell growth rate is low and cannot be determined.
残りの1枚のプレートについて、細胞をホルマリン固定後、1w/vol%クリスタルバイオレット溶液に添加し染色した。各検体濃度に対する細胞生育率(%)をモノセレーター(オリンパス社製)で測定した。
結果を下記表に示す。
For the remaining one plate, cells were fixed with formalin, added to a 1 w / vol% crystal violet solution and stained. The cell growth rate (%) with respect to each sample concentration was measured with a monocerator (Olympus).
The results are shown in the table below.
表1の結果から、例1で調製したセイヨウアカマツ球果抽出物は、「++」という特筆すべき高い美白作用を示すとともに、その高い美白作用を示す濃度において細胞生育率の低下が少ないという、優れた美白剤であることを理解できる。
一方、例2で調製したシベリア落葉松抽出物を添加した試料については、いずれも細胞生育率が低下し過ぎて、美白効果を判定できなかった。
From the results of Table 1, the red pine cone extract prepared in Example 1 exhibits a remarkable whitening effect of “++” and has a low decrease in cell growth rate at a concentration exhibiting the high whitening effect. Can understand that it is an excellent whitening agent.
On the other hand, for the samples to which the Siberian deciduous pine extract prepared in Example 2 was added, the cell growth rate was too low, and the whitening effect could not be determined.
[例4:セイヨウアカマツ球果抽出液の調製]
セイヨウアカマツの球果10kgを細切し、1,3-ブチレングリコールを50vol%含む水−1,3-ブチレングリコール混合液 約70Lを加え、加熱抽出した後、ろ過して、固形物を除去した。ろ液を冷所に3日間以上放置して熟成させ、この工程で生じるオリや沈殿をろ過して除去し、さらに、1,3-ブチレングリコールを50vol%含む水−1,3-ブチレングリコール混合液を追加して、セイヨウアカマツ球果の抽出液約100kgを得た。この抽出液におけるセイヨウアカマツ球果抽出物の含有量は、乾燥固形分で0.8%であった。
[Example 4: Preparation of pine cone extract]
Cut 10 kg of pine cones, add about 70 L of water-1,3-butylene glycol mixed solution containing 50 vol% of 1,3-butylene glycol, extract by heating, and filter to remove solid matter. . The filtrate is left to mature for more than 3 days in a cool place, and the oliage and precipitates produced in this step are removed by filtration, and further mixed with water-1,3-butylene glycol containing 50 vol% 1,3-butylene glycol. The liquid was added to obtain about 100 kg of an extract of Scots pine cones. The content of Scots pine cone extract in this extract was 0.8% in terms of dry solids.
[例5:化粧水1の調製]
下記表に示す組成の化粧水サンプルをそれぞれ調製した。
(製法)
A.下記表中の成分No.1〜8を混合溶解する。
B.下記表中の成分No.9〜17を混合溶解する。
C.BにAを加え、混合し化粧水を得る。
[Example 5: Preparation of lotion 1]
A lotion sample having the composition shown in the following table was prepared.
(Manufacturing method)
A. In the following table, component No. 1-8 are mixed and dissolved.
B. In the following table, component No. 9-17 are mixed and dissolved.
C. A is added to B and mixed to obtain a lotion.
(評価)
調製した各化粧水について、以下の評価を行った。結果を下記表中に示す。
美白効果(白さ、くすみ、しみ等全体観察)に関する評価:
各サンプルを15名ずつに、毎日朝晩2回、顔面に塗布してもらい、1ヶ月間連用した後に、肌状態を自己観察してもらい、下記判断基準で美白効果を評価した。
有効 :使用前に比べかなり改善された。
やや有効:使用前に比べ改善された。
変化なし:使用前に比べ変わらない。
悪化 :使用前に比べ悪化した。
さらに、被検者の評価結果を統計し、各サンプルについて以下の基準で美白効果を評価した。
◎:有効、やや有効の合計人数が12名以上
○:有効/やや有効の合計人数が8〜11名
△:有効/やや有効の合計人数が5〜7名
×:有効/やや有効の合計人数が4名以下
(Evaluation)
The following evaluation was performed about each prepared lotion. The results are shown in the table below.
Evaluation on whitening effect (overall observation such as whiteness, dullness, blotches):
Each sample was applied to the face twice a day in the morning and every day by 15 people, and after one month of continuous use, the skin condition was self-observed, and the whitening effect was evaluated according to the following criteria.
Effective: Significant improvement compared to before use.
Slightly effective: Improved compared to before use.
No change: No change from before use.
Deterioration: Deteriorated compared to before use.
Furthermore, the evaluation results of the subjects were statistically evaluated, and the whitening effect was evaluated for each sample according to the following criteria.
◎: Total number of effective / slightly effective is 12 or more ○: Total number of effective / slightly effective is 8 to 11 △: Total number of effective / slightly effective is 5 to 7 ×: Total number of effective / slightly effective Less than 4
べたつきに関する評価:
専門の官能パネル員 10名により、各サンプルを実際に皮膚に適用し、そのベタツキ感を、以下の基準で評価した。
ベツツキを全く感じない。 5点
ベツツキをほとんど感じない。 4点
ベツツキをやや感じるが気にならない。 3点
ベタツキを感じ、やや気になる。 2点
ベタツキをかなり感じる。 1点
さらに、パネル員の評価結果を統計し、各サンプルについて以下の基準でべたつき感評価した。
◎:10人の平均点が、4点以上
○:10人の平均点が、3点を超え4点未満
△:10人の平均点が、2点を超え3点以下
×:10人の平均点が、2点以下
Evaluation of stickiness:
Each sample was actually applied to the skin by 10 professional panelists, and the stickiness was evaluated according to the following criteria.
I do not feel any stickiness. 5 points Little stickiness. 4 points I feel a little sticky, but I don't mind. 3 points I feel sticky and a little anxious. 2 points I feel quite sticky. 1 point Furthermore, the evaluation result of the panel member was statistically evaluated, and each sample was evaluated for stickiness according to the following criteria.
◎: Average score of 10 people is 4 points or more ○: Average score of 10 people exceeds 3 points and less than 4 points △: Average score of 10 people exceeds 2 points and 3 points or less ×: Average of 10 people 2 points or less
安定性に関する評価:
各サンプルを2個用意しそれぞれ、40℃及び5℃の雰囲気下に1ヶ月保管した後、各サンプルの外観(着色、変色、変臭、沈殿、結晶析出等の外観変化)を目視にて観察し、以下の基準で評価した。
◎:全く変化が見られない。
○:わずかに変化が見られるが問題のない程度。
△:変化がみられる、やや問題となる。
×:大きな変化が見られ、問題である。
Stability assessment:
Prepare two samples and store them for one month at 40 ° C and 5 ° C, respectively, and then visually observe the appearance of each sample (change in appearance such as coloring, discoloration, odor change, precipitation, crystal precipitation, etc.) And evaluated according to the following criteria.
A: No change is seen at all.
○: Slight change but no problem.
Δ: A change is observed, which causes a slight problem.
X: A big change is seen and it is a problem.
本発明品1〜5は、比較品1〜3に比べ、美白効果、べたつきのなさ、安定性の何れの評価においても優れたものであった。 The inventive products 1 to 5 were superior to the comparative products 1 to 3 in any evaluation of the whitening effect, non-stickiness, and stability.
[例6:化粧水2の調製]
(製法)
A.下記成分(1)〜(7)を混合溶解する。
B.下記成分(8)〜(11)を混合溶解する。
C.AにBを加え混合し、化粧水を得た。
(成分) %
(1)クエン酸 0.05
(2)クエン酸ナトリウム 0.2
(3)ピロリドンカルボン酸ナトリウム(50%)液 0.5
(4)グリセリン 3.0
(5)1,3−ブチレングリコール 8.0
(6)セイヨウアカマツ球果抽出液*1 0.05
(7)精製水 残量
(8)エチルアルコール 10.0
(9)香料 適量
(10)防腐剤 適量
(11)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
*1:例4で調製した抽出液
[Example 6: Preparation of lotion 2]
(Manufacturing method)
A. The following components (1) to (7) are mixed and dissolved.
B. The following components (8) to (11) are mixed and dissolved.
C. B was added to A and mixed to obtain a skin lotion.
(Ingredient)%
(1) Citric acid 0.05
(2) Sodium citrate 0.2
(3) Sodium pyrrolidonecarboxylate (50%) solution 0.5
(4) Glycerin 3.0
(5) 1,3-butylene glycol 8.0
(6) Scots pine cone extract * 1 0.05
(7) Purified water remaining amount (8) Ethyl alcohol 10.0
(9) Perfume Appropriate amount (10) Preservative Appropriate amount (11) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
* 1: Extract prepared in Example 4
調製した化粧水は、べたつきもなく、みずみずしい肌感触を有し、美白効果に優れ、変臭、変色、沈殿などもなく安定性も良好なものであった。 The prepared lotion was not sticky, had a fresh skin feel, had an excellent whitening effect, had no odor, discoloration, or precipitation, and had good stability.
[例7:乳液の調製]
(製法)
A.下記成分(1)〜(10)を加熱溶解し、70℃に保つ。
B.下記成分(11)〜(16)を加熱溶解し、70℃に保つ。
C.AにBを加え乳化し、更に下記成分(17)を加え混合する。
D.Cを冷却し、下記成分(18)を加え混合し、乳液を得る。
(成分) %
(1)ステアリン酸 1.0
(2)セタノール 0.5
(3)親油型モノステアリン酸グリセリン 0.5
(4)流動パラフィン 2.0
(5)スクワラン 3.0
(6)ホホバ油 3.0
(7)パルミチン酸セチル 0.2
(8)防腐剤 適量
(9)モノステアリン酸ソルビタン 0.3
(10)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
(11)トリエタノールアミン 0.5
(12)1,3−ブチレングリコール 15.0
(13)グリセリン 3.0
(14)ポリエチレングリコール6000 0.5
(15)セイヨウアカマツ球果抽出液*1 0.1
(16)精製水 残量
(17)カルボキシビニルポリマー1%溶液 8.0
(18)香料 適量
*1:例4で調製した抽出液
[Example 7: Preparation of emulsion]
(Manufacturing method)
A. The following components (1) to (10) are dissolved by heating and maintained at 70 ° C.
B. The following components (11) to (16) are dissolved by heating and maintained at 70 ° C.
C. B is added to A to emulsify, and the following component (17) is further added and mixed.
D. C is cooled, the following component (18) is added and mixed to obtain an emulsion.
(Ingredient)%
(1) Stearic acid 1.0
(2) Cetanol 0.5
(3) Lipophilic glyceryl monostearate 0.5
(4) Liquid paraffin 2.0
(5) Squalane 3.0
(6) Jojoba oil 3.0
(7) Cetyl palmitate 0.2
(8) Preservative appropriate amount (9) Sorbitan monostearate 0.3
(10) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
(11) Triethanolamine 0.5
(12) 1,3-butylene glycol 15.0
(13) Glycerin 3.0
(14) Polyethylene glycol 6000 0.5
(15) Scots pine cone extract * 1 0.1
(16) Purified water remaining amount (17) 1% solution of carboxyvinyl polymer 8.0
(18) Perfume appropriate amount * 1: Extract prepared in Example 4
調製した乳液は、べたつきもなく、なめらかな肌感触を有し、美白効果に優れ、変臭、変色、分離などもなく安定性も良好なものであった。 The prepared emulsion was non-sticky, had a smooth skin feel, had an excellent whitening effect, had no odor, discoloration, separation, etc., and had good stability.
[例8:クリームの調製]
(製法)
A.下記成分(1)〜(13)を加熱溶解し、70℃に保つ。
B.下記成分(14)〜(19)を加熱溶解し、70℃に保つ。
C.AにBを加え乳化し、更に下記成分(20)を加え混合する。
D.Cを冷却し、下記成分(21)を加え混合し、乳液を得る。
(成分) %
(1)ステアリン酸 2.5
(2)セタノール 2.5
(3)親油型モノステアリン酸グリセリン 2.0
(4)ワセリン 2.0
(5)ジペンタエリトリット脂肪酸エステル*1 2.0
(6)ミリスチン酸イソトリデシル 5.0
(7)流動パラフィン 8.0
(8)スクワラン 5.0
(9)ミツロウ 1.0
(10)パルミチン酸セチル 2.0
(11)セスキオレイン酸ソルビタン 0.5
(12)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 1.5
(13)防腐剤 適量
(14)トリエタノールアミン 1.2
(15)1,3−ブチレングリコール 8.0
(16)グリセリン 2.0
(17)ポリエチレングリコール20000 0.5
(18)セイヨウアカマツ球果抽出液*2 1.0
(19)精製水 残量
(20)カルボキシビニルポリマー1%水溶液 10.0
(21)香料 適量
*1:コスモール168AR(日清オイリオグループ社製)
*2:例4で調製した抽出液
[Example 8: Preparation of cream]
(Manufacturing method)
A. The following components (1) to (13) are dissolved by heating and maintained at 70 ° C.
B. The following components (14) to (19) are dissolved by heating and maintained at 70 ° C.
C. B is added to A to emulsify, and the following component (20) is further added and mixed.
D. C is cooled, and the following component (21) is added and mixed to obtain an emulsion.
(Ingredient)%
(1) Stearic acid 2.5
(2) Cetanol 2.5
(3) Lipophilic glyceryl monostearate 2.0
(4) Vaseline 2.0
(5) Dipentaerythritol fatty acid ester * 1 2.0
(6) Isotridecyl myristate 5.0
(7) Liquid paraffin 8.0
(8) Squalane 5.0
(9) Beeswax 1.0
(10) Cetyl palmitate 2.0
(11) Sorbitan sesquioleate 0.5
(12) Polyoxyethylene monooleate (20E.O.)
Sorbitan 1.5
(13) Preservative appropriate amount (14) Triethanolamine 1.2
(15) 1,3-butylene glycol 8.0
(16) Glycerin 2.0
(17) Polyethylene glycol 20000 0.5
(18) Scots pine cone extract * 2 1.0
(19) Purified water remaining amount (20) 1% aqueous solution of carboxyvinyl polymer 10.0
(21) Fragrance appropriate amount * 1: Cosmol 168AR (Nisshin Oillio Group)
* 2: Extract prepared in Example 4
調製したクリームは、べたつきもなく、なめらかでコクのある肌感触を有し、美白効果に優れ、変臭、変色などもなく安定性も良好なものであった。 The prepared cream had no stickiness, had a smooth and rich skin feel, had an excellent whitening effect, had no odor and discoloration, and had good stability.
[例9:美容液の調製]
(製法)
A.下記成分(1)〜(8)を混合溶解する。
B.下記成分(9)〜(17)を混合溶解する。
C.BにAを加え混合し、美容液を得る。
(成分) %
(1)トリ2−エチルヘキサン酸グリセリル 0.1
(2)メドウホーム油 0.05
(3)ホホバ油 0.05
(4)防腐剤 適量
(5)香料 適量
(6)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
(7)イソステアリン酸ポリオキシエチレン硬化
ヒマシ油(50E.O.) 1.5
(8)エチルアルコール 5.0
(9)グリセリン 4.0
(10)ジプロピレングリコール 8.0
(11)1,3−ブチレングリコール 8.0
(12)乳酸ナトリウム 0.5
(13)ピロリドンカルボン酸ナトリウム(50%)液 0.5
(14)セイヨウアカマツ球果抽出液*1 0.5
(15)ヒドロキシエチルセルロース 0.08
(16)アルギン酸ナトリウム 0.05
(17)精製水 残量
*1:例4で調製した抽出液
[Example 9: Preparation of serum]
(Manufacturing method)
A. The following components (1) to (8) are mixed and dissolved.
B. The following components (9) to (17) are mixed and dissolved.
C. A is added to B and mixed to obtain a serum.
(Ingredient)%
(1) Glyceryl tri-2-ethylhexanoate 0.1
(2) Meadow Home Oil 0.05
(3) Jojoba oil 0.05
(4) Preservative appropriate amount (5) perfume appropriate amount (6) polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
(7) Polyoxyethylene hydrogenated isostearate castor oil (50 EO) 1.5
(8) Ethyl alcohol 5.0
(9) Glycerin 4.0
(10) Dipropylene glycol 8.0
(11) 1,3-butylene glycol 8.0
(12) Sodium lactate 0.5
(13) Sodium pyrrolidonecarboxylate (50%) solution 0.5
(14) Scots pine cone extract * 1 0.5
(15) Hydroxyethyl cellulose 0.08
(16) Sodium alginate 0.05
(17) Remaining amount of purified water * 1: Extract prepared in Example 4
調製した美容液は、べたつきもなく、マイルドでなめらかな肌感触を有し、美白効果に優れ、変臭、変色、沈殿などもなく安定性も良好なものであった。 The prepared essence had no stickiness, had a mild and smooth skin feel, had an excellent whitening effect, had no odor, discoloration, precipitation, and had good stability.
[例10:パックの調製]
(製法)
A.下記成分(1)〜(6)を加熱溶解する。
B.下記成分(7)〜(11)を混合溶解する。
C.Aを冷却後、Bを加え混合し、パックを得る。
(成分) %
(1)ポリビニルアルコール 12.0
(2)メチルセルロース 0.1
(3)グリセリン 3.0
(4)1,3−ブチレングリコール 5.0
(5)セイヨウアカマツ球果抽出物*1 0.5
(6)精製水 残量
(7)香料 適量
(8)防腐剤 適量
(9)トリ2−エチルヘキサン酸グリセリル 0.1
(10)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 1.0
(11)エチルアルコール 13.0
*1:例4で調製した抽出液
Example 10: Preparation of pack
(Manufacturing method)
A. The following components (1) to (6) are dissolved by heating.
B. The following components (7) to (11) are mixed and dissolved.
C. After A is cooled, B is added and mixed to obtain a pack.
(Ingredient)%
(1) Polyvinyl alcohol 12.0
(2) Methylcellulose 0.1
(3) Glycerin 3.0
(4) 1,3-butylene glycol 5.0
(5) Scots pine cone extract * 1 0.5
(6) Purified water remaining amount (7) perfume appropriate amount (8) preservative appropriate amount (9) glyceryl tri-2-ethylhexanoate 0.1
(10) Polyoxyethylene monooleate (20E.O.)
Sorbitan 1.0
(11) Ethyl alcohol 13.0
* 1: Extract prepared in Example 4
調整したパックは、肌に塗布すると適度な緊張感があり、パックを剥がしたあとはべたつきもなく、みずみずしいものであり、美白効果に優れ、変臭、変色、分離などのなく安定性も良好なものであった。 The applied pack is moderately tensioned when applied to the skin, is not sticky after being peeled off, is fresh, has an excellent whitening effect, and has good stability without odor, discoloration, separation, etc. It was a thing.
[例11:リキッドファンデーション(O/W型)]
(製法)
A.下記成分(1)〜(7)を加熱溶解する。
B.Aに下記成分(8)〜(11)を加え、均一に混合し、70℃に保つ。
C.下記成分(12)〜(16)を加熱溶解し、70℃に保つ。
D.CにBを加えて乳化する。
E.Dを冷却後、下記成分(17)を加え混合し、リキッドファンデーション(O/W型)を得た。
(成分) %
(1)ステアリン酸 2.0
(2)セタノール 0.5
(3)ベヘニルアルコール 1.0
(4)ワセリン 2.5
(5)流動パラフィン 5.0
(6)自己乳化型モノステアリン酸グリセリン 1.0
(7)防腐剤 適量
(8)酸化チタン 6.0
(9)着色顔料 4.0
(10)マイカ 2.0
(11)タルク 4.0
(12)カルボキシメチルセルロース 0.2
(13)ベントナイト 0.4
(14)セイヨウアカマツ球果抽出液*1 0.1
(15)1,3−ブチレングリコール 8.0
(16)精製水 残量
(17)香料 適量
*1:例4で調製した抽出液
[Example 11: Liquid foundation (O / W type)]
(Manufacturing method)
A. The following components (1) to (7) are dissolved by heating.
B. The following components (8) to (11) are added to A, mixed uniformly, and kept at 70 ° C.
C. The following components (12) to (16) are dissolved by heating and maintained at 70 ° C.
D. B is added to C and emulsified.
E. After cooling D, the following component (17) was added and mixed to obtain a liquid foundation (O / W type).
(Ingredient)%
(1) Stearic acid 2.0
(2) Cetanol 0.5
(3) Behenyl alcohol 1.0
(4) Petrolatum 2.5
(5) Liquid paraffin 5.0
(6) Self-emulsifying glyceryl monostearate 1.0
(7) Preservative appropriate amount (8) Titanium oxide 6.0
(9) Color pigment 4.0
(10) Mica 2.0
(11) Talc 4.0
(12) Carboxymethylcellulose 0.2
(13) Bentonite 0.4
(14) Scots pine cone extract * 1 0.1
(15) 1,3-butylene glycol 8.0
(16) Purified water Remaining amount (17) Perfume appropriate amount * 1: Extract prepared in Example 4
調製したリキッドファンデーションは、伸びひろがりが良く、べたつきもなく、仕上がりも美しく、美白効果に優れ、変臭、分離などもなく安定性も良好なものであった。 The prepared liquid foundation had good spread, no stickiness, a beautiful finish, an excellent whitening effect, no odor and separation, and good stability.
本発明によれば、皮膚外用剤に容易に配合でき、美白効果が高い美白剤、及びそれを含有した安定性が良く、肌感触が良好で、及び高い美白作用のある皮膚外用剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the skin whitening agent which can be easily mix | blended with a skin external preparation, and has a high whitening effect, and the skin external preparation which has the stability containing the good, the skin feel, and a high whitening effect are provided. be able to.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008325423A JP5275779B2 (en) | 2008-03-19 | 2008-12-22 | Whitening agent and external preparation for skin |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008071680 | 2008-03-19 | ||
JP2008071680 | 2008-03-19 | ||
JP2008325423A JP5275779B2 (en) | 2008-03-19 | 2008-12-22 | Whitening agent and external preparation for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009256314A JP2009256314A (en) | 2009-11-05 |
JP5275779B2 true JP5275779B2 (en) | 2013-08-28 |
Family
ID=41384214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008325423A Active JP5275779B2 (en) | 2008-03-19 | 2008-12-22 | Whitening agent and external preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5275779B2 (en) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63284109A (en) * | 1987-05-15 | 1988-11-21 | Sunstar Inc | Beautifying cosmetic |
JP3415199B2 (en) * | 1993-06-30 | 2003-06-09 | 三省製薬株式会社 | External preparation for skin |
JP3696271B2 (en) * | 1994-09-22 | 2005-09-14 | 花王株式会社 | Whitening cosmetics |
JPH0892055A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
JP2000143479A (en) * | 1998-11-05 | 2000-05-23 | Kao Corp | Skin-bleaching cosmetic |
JP2003238425A (en) * | 2002-02-18 | 2003-08-27 | Toyo Shinyaku:Kk | Thyrosinase inhibitor and skin external agent |
JP2004339113A (en) * | 2003-05-14 | 2004-12-02 | Ichimaru Pharcos Co Ltd | Agent for preventing and ameliorating chapped skin by stress |
JP2006045075A (en) * | 2004-08-02 | 2006-02-16 | Yukihiro Hirose | Composition having bleaching action and cosmetic containing the same |
JP4875298B2 (en) * | 2004-12-28 | 2012-02-15 | 一丸ファルコス株式会社 | Trypsin inhibitor |
JP5053519B2 (en) * | 2005-03-30 | 2012-10-17 | 株式会社ナリス化粧品 | Plant trypsin inhibitor |
JP2007063195A (en) * | 2005-08-31 | 2007-03-15 | Katakura Chikkarin Co Ltd | Bleaching agent and external preparation for skin containing the same |
US20090148391A1 (en) * | 2006-01-05 | 2009-06-11 | Symrise Gmbh & Co. Kg | Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds |
-
2008
- 2008-12-22 JP JP2008325423A patent/JP5275779B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009256314A (en) | 2009-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101186081B1 (en) | Functional powders | |
KR20010057585A (en) | External preparation for skin | |
JP4091824B2 (en) | Skin preparation | |
JP3987793B2 (en) | Topical skin preparation | |
JPH11322630A (en) | Antimicrobial agent, external preparation for skin and skin cleaning agent containing the same | |
JP2001220340A (en) | Skin preparation for external use for preventing aging | |
JP4035481B2 (en) | Skin preparation | |
JP2000169329A (en) | Cosmetic composition | |
JP5226200B2 (en) | Sulfated glycosaminoglycan production promoter and skin external preparation containing the same | |
JP2010150173A (en) | Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation | |
JP4088021B2 (en) | Skin external preparation and skin external preparation composition | |
JP2011195539A (en) | Elastase activity inhibitor | |
JP2001261548A (en) | Skin care preparation | |
JP4713032B2 (en) | Skin preparation | |
JP2009256326A (en) | Skin whitening preparation, and skincare preparation | |
JP3895636B2 (en) | Anti-aging agent and external preparation for skin using the same | |
JP2001039854A (en) | Skin preparation for external use | |
JP2002370962A (en) | Bleaching preparation and cosmetic for preventing and improving aging of skin | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
JP2002145752A (en) | Skin care preparation and composition for skin care preparation | |
JP3746260B2 (en) | Topical skin preparation | |
JP2001181170A (en) | Skin care preparation | |
JP5275779B2 (en) | Whitening agent and external preparation for skin | |
JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
JP2002020232A (en) | Skin care preparation and skin care composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110530 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120925 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121002 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121203 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130312 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130423 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130516 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5275779 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |